Page last updated: 2024-09-03

ilomastat and Cirrhosis

ilomastat has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hayashi, M; Hitaka, K; Kakinuma, H; Kamitani, M; Kato, Y; Kojima, N; Mima, M; Mitani, A; Nomura, Y; Nozoe, A; Ohkubo, M; Takeda, T; Takeuchi, T; Tamita, T; Toki, H1
Brocchini, S; Fadda, HM; Khaw, PT; Li, C; Paul, D; Ru, Q; Zloh, M1

Other Studies

2 other study(ies) available for ilomastat and Cirrhosis

ArticleYear
Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.
    Journal of medicinal chemistry, 2022, 06-23, Volume: 65, Issue:12

    Topics: Animals; Fibrosis; Idiopathic Pulmonary Fibrosis; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Zinc

2022
Molecular dynamic simulations of ocular tablet dissolution.
    Journal of chemical information and modeling, 2013, Nov-25, Volume: 53, Issue:11

    Topics: Aqueous Humor; Conjunctiva; Diffusion; Fibrosis; Fluorouracil; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Indoles; Kinetics; Models, Anatomic; Molecular Dynamics Simulation; Solubility; Tablets; Water

2013